SCHEMBL6290671

SCHEMBL6290671

Fc1cccc(Oc2ccc(Oc3ccccc3Oc3cccc(Oc4ccccc4Oc4ccc(Oc5cccc(F)c5)cc4)c3)cc2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 6/20 0.51
SLC6A2 P23975 4/20 0.51
HTR1A P08908 3/20 0.51
SLC6A3 Q01959 3/20 0.51
ALDH1A1 P00352 3/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
MEN1 O00255 1/20 0.48
MITF O75030 1/20 0.48
GAA P10253 1/20 0.48
MAPT P10636 1/20 0.48
GFER P55789 1/20 0.48
KMT2A Q03164 1/20 0.48
NLRP1 Q9C000 1/20 0.48
NOD2 Q9HC29 1/20 0.48
L3MBTL1 Q9Y468 2/20 0.45
PGR P06401 1/20 0.45
MAPK1 P28482 1/20 0.45
HTT P42858 1/20 0.45
HTR2A P28223 2/20 0.45
MMP2 P08253 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6293934 1.00 SLC6A4 (0.51) SLC6A4SLC6A2HTR1ASLC6A3ALDH1A1
SCHEMBL6293880 1.00 SLC6A4 (0.51) SLC6A4SLC6A2HTR1ASLC6A3ALDH1A1
SCHEMBL6290509 1.00 SLC6A4 (0.51) SLC6A4SLC6A2HTR1ASLC6A3ALDH1A1
SCHEMBL6293959 0.98 SLC6A4 (0.53) SLC6A4SLC6A2HTR1ASLC6A3ALDH1A1
SCHEMBL6293852 0.98 SLC6A4 (0.53) SLC6A4SLC6A2HTR1ASLC6A3ALDH1A1
SCHEMBL6293859 0.98 SLC6A4 (0.53) SLC6A4SLC6A2HTR1ASLC6A3ALDH1A1
SCHEMBL6289839 0.98 SLC6A4 (0.53) SLC6A4SLC6A2HTR1ASLC6A3ALDH1A1
SCHEMBL6290506 0.96 SLC6A4 (0.51) SLC6A4SLC6A2HTR1ASLC6A3ALDH1A1
SCHEMBL6289809 0.96 SLC6A4 (0.54) SLC6A4SLC6A2HTR1ASLC6A3ALDH1A1
SCHEMBL6289276 0.96 SLC6A4 (0.54) SLC6A4SLC6A2HTR1ASLC6A3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6933411-B2 Aromatic diamine and polyimide thereof MITSUI CHEMICALS, INC. (JP) 2005-08-23 US disclosed
US-6737503-B2 LOW TEMPERATURE ADHESIVE BONDING MITSUI CHEMICALS, INC. (JP) 2004-05-18 US disclosed
US-20040082754-A1 Novel aromatic diamine and polyimide thereof MITSUI CHEMICALS, INC. (JP) 2004-04-29 US disclosed
US-20030092870-A1 Novel aromatic diamine and polyimide thereof MITSUI CHEMICALS, INC. (JP) 2003-05-15 US disclosed
EP-1288191-A2 Novel aromatic diamine and polyimide thereof Mitsui Chemicals, Inc. (JP) 2003-03-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030092870-A1 Novel aromatic diamine and polyimide thereof DDT, AOC1, H1-4 SLC6A4 1103/4885SLC6A2 2617/4885HTR1A 2098/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.